Compare CVS Health Corp (CVS) vs Dell Technologies Inc (DELL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs Dell Technologies Inc — how do they compare? CVS Health Corp trades at $86.25 (market cap $112.49B), while Dell Technologies Inc trades at $582.94 (market cap $368.11B). The key difference: Dell Technologies Inc is far larger — about 3.3× CVS Health Corp's market cap, and CVS Health Corp pays the higher dividend (3.02%). Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and Dell Technologies Inc for 57 Days on average.
| CVS | DELL | |
|---|---|---|
Market Cap | $112.49B | $368.11B |
Volume | 8,467,392 | 3,975,387 |
Sector | Health | Technology |
52-Week High | $110.60 | $588.67 |
52-Week Low | $70.08 | $111.10 |
Typical Hold Time | 83 Days | 57 Days |
Enterprise Value | $174.83B | $391.01B |
Dividend Yield | 3.02% | 0.44% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $87.80, up 1.59% today, with strong analyst support (85% buy ratings) and a $111.20 consensus price target suggesting 27% upside. Recent quarterly earnings have consistently beaten expectations, with Q2 2026 EPS of $2.58 surpassing the $1.87 estimate. Revenue growth remains solid, reaching $402.07B in 2025, though net margins compressed to 1.18%. The technical picture shows bullish momentum with current price near key support at $87.
CVS presents a compelling value opportunity with attractive valuation multiples (P/E 23.21, P/S 0.27) and dividend stability, but faces margin pressure from healthcare cost trends. The stock's upside depends on maintaining earnings momentum amid reimbursement challenges and regulatory scrutiny highlighted in recent legal investigations.
Dell Technologies (DELL) trades at $574.74, up 0.16% today, with a bullish technical outlook from moving averages and a consensus analyst price target of $566.35. The stock is buoyed by strong AI server demand, with Q2 2026 EPS of $7.04 beating estimates by 43% and revenue guidance for fiscal 2027 raised to approximately $192 billion. Recent news highlights a 20% dividend increase and a $74 billion AI server backlog, though the RSI suggests mild overbought conditions near resistance at $584.
The outlook for Dell is positive, driven by explosive growth in AI infrastructure orders and robust financial performance. Key opportunities include expanding profit margins and capital returns, while risks involve execution on the large backlog, competitive pressures in the server market, and reliance on continued AI investment trends. The stock's valuation at a P/E of 33.68 reflects high growth expectations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About Dell Technologies Inc
VMware is an industry titan in virtualizing IT infrastructure and became a stand-alone entity after spinning off from Dell Technologies in November 2021. The software provider operates in the three segments: licenses
Read more on DELL →
